Pravastatin as a therapeutic agent for atypical antipsychotic-induced metabolic syndrome in patients with schizophrenia.
Pae
C-U
CU
Department of Psychiatry, Kangnam St. Mary's Hospital, Catholic University of Korea College of Medicine, Seoul, South Korea.